Clinical guidelines versus universal molecular testing: Are we ready to choose an optimal strategy for lynch syndrome identification?

American Journal of Gastroenterology

Volumn 103, Issue 11, 2008, Pages 2837-2840

  Byfield, Stacey A DaCosta ^a   Syngal, Sapna ^b,c,d  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b DANA FARBER CANCER INSTITUTE   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER RISK; CANCER SCREENING; COLORECTAL CANCER; FAMILIAL CANCER; GENETIC COUNSELING; HEALTH CARE SYSTEM; HUMAN; MICROSATELLITE INSTABILITY; MOLECULAR GENETICS; PHYSICIAN; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW;

COLORECTAL NEOPLASMS, HEREDITARY NONPOLYPOSIS; GENETIC SCREENING; HUMANS; PRACTICE GUIDELINES AS TOPIC;

EID: 55349086520     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1111/j.1572-0241.2008.02091.x     Document Type: Review

References (20)

1. Vasen HF. Clinical description of the Lynch syndrome [hereditary nonpolyposis colorectal cancer (HNPCC)]. Fam Cancer 2005 4 : 219 25.
2. Loughrey MB, Waring PM, Tan A, et al. Incorporation of somatic BRAF mutation testing into an algorithm for the investigation of hereditary non-polyposis colorectal cancer. Fam Cancer 2007 6 : 301 10.
3. de Jong AE, Hendriks YM, Kleibeuker JH, et al. Decrease in mortality in Lynch syndrome families because of surveillance. Gastroenterology 2006 130 : 665 71.
4. Syngal S, Weeks JC, Schrag D, et al. Benefits of colonoscopic surveillance and prophylactic colectomy in patients with hereditary nonpolyposis colorectal cancer mutations. Ann Intern Med 1998 129 : 787 96.
5. Vasen HF, Moslein G, Alonso A, et al. Guidelines for the clinical management of Lynch syndrome (hereditary non-polyposis cancer). J Med Genet 2007 44 : 353 62.
6. Vasen HF, Mecklin JP, Khan PM, et al. The International Collaborative Group on Hereditary Non-Polyposis Colorectal Cancer (ICG-HNPCC). Dis Colon Rectum 1991 34 : 424 5.
7. Vasen HF, Watson P, Mecklin JP, et al. New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC. Gastroenterology 1999 116 : 1453 6.
8. Rodriguez-Bigas MA, Boland CR, Hamilton SR, et al. A National Cancer Institute Workshop on Hereditary Nonpolyposis Colorectal Cancer Syndrome: Meeting highlights and Bethesda Guidelines. J Natl Cancer Inst 1997 89 : 1758 62.
9. Umar A, Boland CR, Terdiman JP, et al. Revised Bethesda guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. J Natl Cancer Inst 2004 96 : 261 8.
10. Balmana J, Stockwell DH, Steyerberg EW, et al. Prediction of MLH1 and MSH2 mutations in Lynch syndrome. JAMA 2006 296 : 1469 78.
11. Barnetson RA, Tenesa A, Farrington SM, et al. Identification and survival of carriers of mutations in DNA mismatch-repair genes in colon cancer. N Engl J Med 2006 354 : 2751 63.
12. Chen S, Wang W, Lee S, et al. Prediction of germline mutations and cancer risk in the Lynch syndrome. JAMA 2006 296 : 1479 87.
13. Julie C, Tresallet C, Brouquet A, et al. Identification in daily practice of patients with Lynch Syndrome (hereditary nonpolyposis colorectal cancer): Revised Bethesda guidelines-based approach versus molecular screening. Am J Gastroenterol 2008 103 : 2825 35.
14. Bessa X, Balleste B, Andreu M, et al. A prospective, multicenter, population-based study of BRAF mutational analysis for Lynch syndrome screening. Clin Gastroenterol Hepatol 2008 6 : 206 14.
15. Pinol V, Castells A, Andreu M, et al. Accuracy of revised Bethesda guidelines, microsatellite instability, and immunohistochemistry for the identification of patients with hereditary nonpolyposis colorectal cancer. JAMA 2005 293 : 1986 94.
16. Rodriguez-Moranta F, Castells A, Andreu M, et al. Clinical performance of original and revised Bethesda guidelines for the identification of MSH2/MLH1 gene carriers in patients with newly diagnosed colorectal cancer: Proposal of a new and simpler set of recommendations. Am J Gastroenterol 2006 101 : 1104 11.
17. Hampel H, Frankel WL, Martin E, et al. Screening for the Lynch syndrome (hereditary nonpolyposis colorectal cancer). N Engl J Med 2005 352 : 1851 60.
18. Grover S, Stoffel EM, Bussone L, et al. Physician assessment of family cancer history and referral for genetic evaluation in colorectal cancer patients. Clin Gastroenterol Hepatol 2004 2 : 813 9.
19. Murff HJ, Greevy RA, Syngal S. The comprehensiveness of family cancer history assessments in primary care. Community Genet 2007 10 : 174 80.
20. Schroy PC 3rd., Barrison AF, Ling BS, et al. Family history and colorectal cancer screening: A survey of physician knowledge and practice patterns. Am J Gastroenterol 2002 97 : 1031 6.